SMTL ID : 4o97.1

Crystal structure of matriptase in complex with inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

monomer

Ligands

1 x CYS- GLY- LEU- ARG: Peptide CGLR(Non-covalent)

CYS-GLY-LEU-ARG.1: 11 residues within 4Å: Chain A: G.10, E.11, P.13, W.14, R.114, P.115, I.116, C.117, G.202, R.203, I.204 9 PLIP interactions: 9 interactions with chain A Hydrogen bonds: A:E.11, A:R.114, A:R.114, A:R.114, A:P.115, A:C.117, A:G.202, A:I.204 Water bridges: A:R.114

1 x NTX: N-(trans-4-aminocyclohexyl)-3,5-bis[(3-carbamimidoylbenzyl)oxy]benzamide(Non-covalent)

NTX.2: 16 residues within 4Å: Chain A: D.47, F.92, T.93, F.94, Q.169, D.185, S.186, C.187, Q.188, S.191, V.210, W.212, G.213, G.215, C.216, G.223 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:F.94, A:V.210, A:W.212, A:W.212 Hydrogen bonds: A:Q.169, A:Q.169, A:D.185, A:S.186 Water bridges: A:W.212 pi-Stacking: A:F.94 pi-Cation interactions: A:H.42

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Goswami, R. et al., Structure-guided discovery of 1,3,5 tri-substituted benzenes as potent and selective matriptase inhibitors exhibiting in vivo antitumor efficacy. Bioorg.Med.Chem. (2014)

Release Date

2014-05-28

Peptides

Suppressor of tumorigenicity 14 protein: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Suppressor of tumorigenicity 14 protein

Related Entries With Identical Sequence